CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

Cited by (454)

Items 201–300 of 454

1. Toxicoepigenetics and Environmental Health: Challenges and Opportunities
   Laurie Kathleen Svoboda, Bambarendage P. U. Perera, Rachel K. Morgan, Katelyn M. Polemi, Junru Pan, Dana C. Dolinoy · 2022 · Chemical Research in Toxicology
2. PIWI-Interacting RNA (piRNA) and Epigenetic Editing in Environmental Health Sciences
   Bambarendage P. U. Perera, Rachel K. Morgan, Katelyn M. Polemi, Kimmie E. Sala-Hamrick, Laurie Kathleen Svoboda, Dana C. Dolinoy · 2022 · Current Environmental Health Reports
3. Mapping the functional impact of non-coding regulatory elements in primary T cells through single-cell CRISPR screens
   Celia Alda-Catalinas, Ximena Ibarra-Soria, Christina Flouri, Jorge Esparza Gordillo, Diana L. Cousminer, Anna Hutchinson, Bin Sun, William G. Pembroke, Sebastian Ullrich, Adam Krejčí et al. · 2024 · Genome biology
4. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes
   Nathan T Lawlor, Michael L. Stitzel · 2019 · Molecular Metabolism
5. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis
   Ami M. Kabadi, Leah Machlin, Nikita Dalal, Rhianna E. Lee, Ian C. McDowell, Nirav N. Shah, Lauren Drowley, Scott H. Randell, Timothy E. Reddy · 2021 · Journal of Cystic Fibrosis
6. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation
   Jiachen Lin, Yangzhong Zhou, Jiaqi Liu, Jia Chen, Wei‐Sheng Chen, Sen Zhao, Zhihong Wu, Nan Wu · 2017 · Journal of Cellular Biochemistry
7. Assessing genome-wide dynamic changes in enhancer activity during early mESC differentiation by FAIRE-STARR-seq
   Laura V. Glaser, Mara Steiger, Alisa Fuchs, Alena van Bömmel, Edda Einfeldt, Ho‐Ryun Chung, Martin Vingron, Sebastiaan H. Meijsing · 2021 · Nucleic Acids Research
8. Elucidating the importance and regulation of key enhancers for human MEIS1 expression
   Ping Xiang, Xining Yang, Leo Escano, Ishpreet Dhillon, Edith M. Schneider, Jack Clemans-Gibbon, Wei Wei, Jasper Wong, Simon Xufeng Wang, Derek Tam et al. · 2022 · Leukemia
9. High-Throughput CRISPR Screening in Hematological Neoplasms
   Ancos-Pintado, Raquel, Bragado-García, Irene, Morales, María Luz, García-Vicente, Roberto, Arroyo-Barea, Andrés, Rodríguez-García, Alba, Martínez-López, Joaquín, Linares, María, Hernández-Sánchez, María · 2022 · Cancers
10. Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression
    Lin Lin, Benjamin R. Holmes, Max W. Shen, Darnell Kammeron, Niels Geijsen, David Kenneth Gifford, Richard I. Sherwood · 2020 · Cell Reports
11. Unveiling the regulatory potential of the non-coding genome: Insights from the human genome project to precision medicine
    Paola Ruffo, Bryan J. Traynor, Francesca Luisa Conforti · 2025 · Genes & Diseases
12. Identification of rheumatoid arthritis causal genes using functional genomics
    James Ding, Gisela Orozco · 2019 · Scandinavian Journal of Immunology
13. Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis
    William Pontius, Ellen S. Hong, Zachary J. Faber, Jeremy Gray, Craig D. Peacock, Ian Bayles, Katreya Lovrenert, Diana H. Chin, Berkley E. Gryder, Cynthia F. Bartels et al. · 2023 · Nature Communications
14. Electrophilic oligodeoxynucleotide synthesis using dM-Dmoc for amino protection
    Shahien Shahsavari, Dhananjani N. A. M. Eriyagama, Bhaskar Halami, Vagarshak Begoyan, Marina Tanasova, Jinsen Chen, Shiyue Fang · 2019 · Beilstein Journal of Organic Chemistry
15. Screening for functional transcriptional and splicing regulatory variants with GenIE
    Sarah Cooper, Jeremy Schwartzentruber, Erica Bello, Eve L. Coomber, Andrew Roger Bassett · 2020 · Nucleic Acids Research
16. Regulation of Gene Expression and the Elucidative Role of CRISPR-Based Epigenetic Modifiers and CRISPR-Induced Chromosome Conformational Changes
    Andrea Martella, David I. Fisher · 2021 · The CRISPR Journal
17. Genome editing to define the function of risk loci and variants in rheumatic disease
    Yuriy Baglaenko, Dana Macfarlane, Alexander Marson, Peter Andrija Nigrovic, Soumya Raychaudhuri · 2021 · Nature Reviews Rheumatology
18. Genome-wide annotation of gene regulatory elements linked to cell fitness
    Maria ter Weele, Tyler S. Klann, Alejandro Barrera, Adarsh R. Ettyreddy, Siyan Liu, Ryan A. Rickels, Julien Bryois, Simon W. Jiang, Shaunak Sanjay Adkar, Nahid Iglesias et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
19. The epigenome editors: How tools such as CRISPR offer new details about epigenetics
    Willyard, Cassandra · 2017 · Nature Medicine
20. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing
    Sarah Balderston, Gabrielle Clouse, Juan José Ripoll, Grace K. Pratt, Giedrius Gasiūnas, Jens-Ole Bock, Eric Bennett, Kiana Aran · 2021 · The CRISPR Journal
21. Sufficiency analysis of estrogen responsive enhancers using synthetic activators
    Matthew Ginley-Hidinger, Julia B. Carleton, Adriana Cristina Rodriguez, Kristofer C. Berrett, Jason Gertz · 2019 · Life Science Alliance
22. Understanding Regulatory Mechanisms of Brain Function and Disease through 3D Genome Organization
    Weifang Liu, Wujuan Zhong, Jiawen Carmen Chen, Bo Huang, Ming Hu, Yun Li · 2022 · Genes
23. Dissecting Molecular Phenotypes Through FACS-Based Pooled CRISPR Screens
    Oriana Genolet, Liat Ravid Lustig, Edda G. Schulz · 2022 · Methods in molecular biology
24. Characterization of diverse Cas9 orthologs for genome and epigenome editing
    Gabriel L. Butterfield, Dahlia Rohm, Avery Roberts, Matthew A. Nethery, Anthony J. Rizzo, Daniel J. Morone, Lisa Garnier, Nahid Iglesias, Rodolphe Barrangou, Charles A. Gersbach · 2025 · Proceedings of the National Academy of Sciences
25. Using Chromatin Architecture to Understand the Genetics and Transcriptomics of Juvenile Idiopathic Arthritis
    Haeja A. Kessler, Kaiyu Jiang, James N. Jarvis · 2018 · Frontiers in Immunology
26. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases
    Desh Deepak Singh, R. David Hawkins, Riitta Lahesmaa, Subhash Kumar Tripathi · 2019 · Seminars in Cell and Developmental Biology
27. Cancer induction and suppression with transcriptional control and epigenome editing technologies
    Shota Nakade, Takashi Yamamoto, Tetsushi Sakuma · 2017 · Journal of Human Genetics
28. Discovering functional sequences with RELICS, an analysis method for CRISPR screens
    Patrick C. Fiaux, Hsiuyi V. Chen, Poshen B. Chen, Aaron R. Chen, Graham McVicker · 2020 · PLoS Computational Biology
29. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller · 2019 · Comprehensive physiology
30. Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production
    Laavanya Sankaranarayanan, Kelly Brewer, Shauna Morrow, Graham D. Johnson, Alejandro Barrera, Revathy Venukuttan, Ryan K. Sisk, Andrea Elizabeth Dunaif, Timothy E. Reddy · 2025 · Nature Communications
31. Haplotype-specific chromatin looping reveals genetic interactions of regulatory regions modulating gene expression in 8p23.1
    Mariana Saint Just Ribeiro, Pulak Tripathi, Bahram Namjou, John B. Harley, Iouri Chepelev · 2022 · Frontiers in Genetics
32. CRISPR-Based Tools for Fighting Rare Diseases
    Qingyang Li, Yanmin Gao, Haifeng Wang · 2022 · Life
33. CRISPR/Cas-based customization of pooled CRISPR libraries
    Jiyeon Kweon, Jin‐Soo Kim, An-Hee Jang, Yongsub Kim · 2018 · PLoS ONE
34. Index and biological spectrum of accessible DNA elements in the human genome
    Wouter R. A. Meuleman, Alexander Muratov, Eric Rynes, Jessica M. Halow, Kristen Lee, Daniel Bates, Morgan Diegel, Douglas Dunn, Fidencio Jun Neri, Athanasios Teodosiadis et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
35. An encyclopedia of human enhancer–gene regulatory interactions
    Andreas R. Gschwind, Kristy S. Mualim, Alireza Karbalayghareh, Maya U. Sheth, Kushal K. Dey, Evelyn Jagoda, Ramil Nurtdinov, Wang Xi, Anthony S. Tan, James Galante et al. · 2026 · Nature
36. SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
    You‐Yu Lin, Wenting Zhong, Qili Lin, Yan Ye, ShengZhao Li, Hui Chen, Hongxia Liu, Luyun Xu, Wei Zhuang, Shaoqing Chen et al. · 2023 · PubMed Central
37. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates the ZNF334 gene to inhibit the growth of colorectal cancer
    Qin Wang, Chen Ma, Huixian Mao, Jinhui Wang · 2024 · International Journal of Biological Macromolecules
38. Inducible CRISPR Epigenome Systems Mimic Cocaine Induced Bidirectional Regulation of Nab2 and Egr3
    Eric Y. Choi, Daniela Franco, Catherine A. Stapf, Madeleine Gordin, Amanda Chow, Kara K. Cover, Ramesh Chandra, Mary Kay Lobo · 2023 · Journal of Neuroscience
39. Evaluating Chromatin Accessibility Differences Across Multiple Primate Species Using a Joint Modeling Approach
    Lee Edsall, Alejandro Berrío, William H. Majoros, Devjanee Swain-Lenz, Shauna Morrow, Yoichiro Shibata, Alexias Safi, Gregory A. Wray, Gregory E. Crawford, Andrew S. Allen · 2019 · Genome Biology and Evolution
40. Integrating Biomaterials and Genome Editing Approaches to Advance Biomedical Science
    Amr A. Abdeen, Brian D. Cosgrove, Charles A. Gersbach, Krishanu Saha · 2021 · Annual Review of Biomedical Engineering
41. Animal Cell Technology
    Byong H. Lee · 2021 · Wiley eBooks
42. Functional genomic assays to annotate enhancer–promoter interactions genome wide
    Alden King-Yung Leung, Yao Li, Haiyuan Yu · 2022 · Human Molecular Genetics
43. Linking regulatory variants to target genes by integrating single-cell multiome methods and genomic distance
    Elizabeth Dorans, Karthik A. Jagadeesh, Kushal K. Dey, Alkes L. Price · 2025 · Nature Genetics
44. Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity
    Eric Alves, Emily McLeish, Pilar Blancafort, Jérôme D. Coudert, Silvana Gaudieri · 2021 · Frontiers in Immunology
45. Programmable Live‐Cell CRISPR Imaging with Toehold‐Switch‐Mediated Strand Displacement
    Yaya Hao, Jiang Li, Qian Li, Luhao Zhang, Jiye Shi, Xueli Zhang, Ali K. Aldalbahi, Lihua Wang, Chunhai Fan, Fei Wang · 2020 · Angewandte Chemie
46. The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors
    Verena E. Deutschmeyer, Antje Maria Richter · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
47. Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance
    Ronay Çetin, Eva Quandt, Manuel Kaulich · 2021 · Cells
48. Mapping the residue specificities of epigenome enzymes by yeast surface display
    Alison C. Waldman, Balaji M. Rao, Albert J. Keung · 2021 · Cell chemical biology
49. Pooled image-base screening of mitochondria with microraft isolation distinguishes pathogenic mitofusin 2 mutations
    Alex L. Yenkin, John C. Bramley, Colin L. Kremitzki, Jason E. Waligorski, Mariel J. Liebeskind, Xinyuan E. Xu, Vinay Chandrasekaran, Maria A. Vakaki, Graham W. Bachman, Robi David Mitra et al. · 2022 · Communications Biology
50. Disruptive non-disruptive applications of CRISPR/Cas9
    Jonathan Leo Schmid-Burgk · 2017 · Current Opinion in Biotechnology
51. Transcriptome modeling and phenotypic assays for cancer precision medicine
    Euna Jeong, Sung Ung Moon, Mee Song, Sukjoon Yoon · 2017 · Archives of Pharmacal Research
52. CLUE: a bioinformatic and wet-lab pipeline for multiplexed cloning of custom sgRNA libraries
    Martin Becker, Heidi Noll‐Puchta, Diana Amend, Florian Nolte, Christiane Fuchs, Irmela Jeremias, Christian Joerg Braun · 2020 · Nucleic Acids Research
53. Multi-center integrated analysis of non-coding CRISPR screens
    David Yao, Josh Tycko, Jin Woo Oh, Lexi R. Bounds, Sager J. Gosai, Lazaros Lataniotis, Ava Mackay-Smith, Benjamin R. Doughty, Idan Gabdank, Henri Schmidt et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
54. Recent advances in CRISPR-Cas systems for colorectal cancer research and therapeutics
    Saeideh Khorshid Sokhangouy, Farzaneh Lal Alizadeh, Malihe Lotfi, Samaneh Sharif, Atefeh Ashouri, Yasamin Yoosefi, Saeed Bozorg Qomi, Mohammad Reza Abbaszadegan · 2024 · Expert Review of Molecular Diagnostics
55. Enhancer–promoter entanglement explains their transcriptional interdependence
    Anil K. Panigrahi, David Michael Lonard, Bert W. O’Malley · 2023 · Proceedings of the National Academy of Sciences
56. CRISPR Editing in Biological and Biomedical Investigation
    Han Zhang, Nami McCarty · 2017 · Journal of Cellular Biochemistry
57. Parallel, Large-Scale, and Long Synthetic Oligodeoxynucleotide Purification Using the Catching Full-Length Sequence by Polymerization Technique
    Dhananjani N. A. M. Eriyagama, Shahien Shahsavari, Bhaskar Halami, Bao‐Yuan Lu, Fengping Wei, Shiyue Fang · 2018 · Organic Process Research & Development
58. Preparation and characterization of DNA array slides via surface Michael addition
    Fang Cheng, Xiaochun Ma, Qiancheng Feng, Hanqi Wang, Meng Yin, Wei Jian He · 2019 · Biointerphases
59. A simple and rapid method for enzymatic synthesis of CRISPR-Cas9 sgRNA libraries
    Joshua D. Yates, Robert C Russell, Nathaniel Barton, H. Joseph Yost, Jonathon T. Hill · 2021 · Nucleic Acids Research
60. Molecular mechanism for the multiple sclerosis risk variant rs17594362
    Dongkyeong Kim, Yungki Park · 2019 · Human Molecular Genetics
61. Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications
    Daisy Precilla Senthilathiban, Shreyas S. Kuduvalli, T. S. Anitha · 2021 · Molecular Biotechnology
62. Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function
    Sean R. McCutcheon, Adam M. Swartz, Michael C. Brown, Alejandro Barrera, Christian McRoberts Amador, Keith Siklenka, Lucas L. Humayun, James M. Isaacs, Timothy E. Reddy, Smita K. Nair et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
63. Discovery of hypercompact epigenetic modulators for persistent CRISPR-mediated gene activation
    Giovanni A. Carosso, Robin W. Yeo, T. Blair Gainous, Muhammad Zaki Jawaid, Yang Xiao, James Y.S. Kim, Kavita Jadhav, Nina Juan-Sing, Siddaraju V. Boregowda, Vincent Cutillas et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
64. Evaluation of chromatin accessibility in prefrontal cortex of schizophrenia cases and controls
    Bryois, Julien, Garrett, Melanie E, Song, Lingyun, Safi, Alexias, Giusti-Rodriguez, Paola, Johnson, Graham D, Demur, Alfonso Buil, Fullard, John F, Roussos, Panos, Sklar, Pamela et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
65. FTH1 overexpression using a dCasRx translation enhancement system protects the kidney from calcium oxalate crystal-induced injury
    Ziqi He, Caitao Dong, Tianbao Song, Jiawei Zhou, Tao Xu, Ruyuan He, Sheng Li · 2024 · Cellular & Molecular Biology Letters
66. MethNet: a robust approach to identify regulatory hubs and their distal targets from cancer data
    Theodore Sakellaropoulos, Catherine Do, Guimei Jiang, Giulia Cova, Peter Meyn, Dacia Dimartino, Sitharam Ramaswami, Adriana Heguy, Aristotelis Tsirigos, Jane A. Skok · 2024 · Nature Communications
67. Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment
    Asif Nawaz, Nur Syamimi Ariffin, Tin Wui Wong · 2025 · Asian Journal of Pharmaceutical Sciences
68. Comparative analysis of genome editing systems, Cas9 and BE3, in silkworms
    Yue Liu, Yufeng Li, Yan Liang, Ting Wang, Chengfei Yang, Sanyuan Ma, Qingyou Xia · 2020 · International Journal of Biological Macromolecules
69. CRISPR/Cas9-based Gene Therapies for Fighting Drug Resistance Mediated by Cancer Stem Cells
    Sorayya Ghasemi, Masoumeh Eliyasi Dashtaki · 2022 · Current Gene Therapy
70. Translating non-coding genetic associations into a better understanding of immune-mediated disease
    Christina T. Stankey, James Christopher Lee · 2023 · Disease Models & Mechanisms
71. Heart Enhancers: Development and Disease Control at a Distance
    Xuefei Yuan, Ian C. Scott, Michael D. Wilson · 2021 · Frontiers in Genetics
72. CRISPR-Cas: Removing Boundaries of the Nature
    Nicat Cebrailoglu, Ali Burask Yildiz, Özlem Akkaya, Yelda Özden Çiftçi · 2019 · European Journal of Biology
73. Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing
    Tyler S. Klann, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach · 2018 · Methods in molecular biology
74. Simultaneous Epigenetic Perturbation and Genome Imaging Reveal Distinct Roles of H3K9me3 in Chromatin Architecture and Transcription
    Ying Feng, Yao Wang, Xiangnan Wang, Xiaohui He, Yang Chen, Ardalan Naseri, Thoru Pederson, Jing Zheng, Shaojie Zhang, Xiao Xiao et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
75. Deciphering enhancers of hearing loss genes for efficient and targeted gene therapy of hereditary deafness
    Simeng Zhao, Qiuxiang Yang, Zehua Yu, Cenfeng Chu, Shengqi Dai, Hongli Li, Min Diao, Lingyue Feng, Junzi Ke, Yilin Xue et al. · 2025 · Neuron
76. Precise epigenomic editing with a SunTag-based modular epigenetic toolkit
    Subhrangshu Guhathakurta, Levi Adams, Inhye Jeong, Anishaa Sivakumar, Mingyu Cha, Mariana Bernardo Fiadeiro, Haiyan Hu, Yoon‐Seong Kim · 2022 · Epigenetics
77. Characterization of transcriptional enhancers in the chicken genome using CRISPR-mediated activation
    Jeong Hoon Han, Hong Jo Lee, Tae Hyun Kim · 2023 · Frontiers in Genome Editing
78. Transforming the CRISPR/dCas9-based gene regulation technique into a forward screening tool in Plasmodium falciparum
    Amuza Byaruhanga Lucky, Chengqi C. Q. Wang, Xiaolian Li, Xiaoying Liang, Azhar Muneer, Jun Miao · 2024 · iScience
79. Integrated enhancer regulatory network by enhancer–promoter looping in gastric cancer
    Tianhui Zhu, Atsushi Okabe, Genki Usui, Ryoji Fujiki, Daichi Komiyama, Kie Kyon Huang, Motoaki Seki, Masaki Fukuyo, Hiroyuki Abé, Meng Ning et al. · 2024 · NAR Cancer
80. SpRY-mediated screens facilitate functional dissection of non-coding sequences at single-base resolution
    Yao Yao, Zhiwei Zhou, Xiaoling Wang, Zhirui Liu, Yixin Zhai, Xiaolin Chi, Jingyi Du, Liheng Luo, Zhigang Zhao, Xiaoyue Wang et al. · 2024 · Cell Genomics
81. Edited course of biomedical research: leaping forward with CRISPR
    Patrick J. Collins, Christopher M. Hale, Han Xu · 2017 · Pharmacological Research
82. CRISPR/Cas9 in Male Factor Infertility
    Davide Cina, Drew Phillips, Ryan Kendrick Flannigan · 2020 · Current Tissue Microenvironment Reports
83. Coupling high-throughput mapping with proteomics analysis delineates cis-regulatory elements at high resolution
    Ting Wu, Danli Jiang, Meijuan Zou, Wei Sun, Di Wu, Jing Cui, Ian Huntress, Xinxia Peng, Gang Li · 2021 · Nucleic Acids Research
84. Target Discovery for Precision Medicine Using High-Throughput Genome Engineering
    Xinyi Guo, Poonam Chitale, Neville E. Sanjana · 2017 · Advances in experimental medicine and biology
85. Categorical Matrix Completion With Active Learning for High-Throughput Screening
    Junyi Chen, Junhui Hou, Ka‐Chun Wong · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
86. Computational Methods for Analysis of Large-Scale CRISPR Screens
    Xueqiu Lin, Augustine Chemparathy, Marie F. La Russa, Timothy Daley, Lei S. Qi · 2020 · Annual Review of Biomedical Data Science
87. Gene delivery into cells and tissues
    Christopher E. Nelson, Craig L. Duvall, Aleš Prokop, Charles A. Gersbach, Jeffrey M. Davidson · 2020 · Elsevier eBooks
88. AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells
    Ricardo Iván Martínez-Zamudio, Pierre‐François Roux, José Américo Nabuco Leva Ferreira de Freitas, Lucas J. Robinson, Grégory R G Doré, Bin Sun, Jesús Gil, Utz Herbig, Oliver Bischof · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
89. Integrative PTEN Enhancer Discovery Reveals a New Model of Enhancer Organization
    Christian G. Cerda-Smith, Haley M. Hutchinson, Annie Liu, Viraat Y. Goel, Corriene Sept, Holly Kim, Salvador Casaní-Galdón, Katherine G. Burkman, Christopher F. Bassil, Anders S. Hansen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
90. Predicting the effect of CRISPR-Cas9-based epigenome editing
    Sanjit Singh Batra, Alan Cabrera, Jeffrey P. Spence, Jacob Goell, Selvalakshmi Selvaraj Anand, Isaac B. Hilton, Yun S. Song · 2026 · eLife
91. Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function
    Sarah Arroyo Villora, Paula Castellanos Silva, Tamara Zenz, Ji Sun Kwon, Nico A. Schlaudraff, Dafina Nitaj, Cornelia Meckbach, Reinhard Dammann, Antje Maria Richter · 2024 · Genes
92. Knowledge mapping and current trends of global research on CRISPR in the field of cancer
    Han Liu, Zongwei Lv, Gong Zhang, Xia Wang, Yuan Wang, Kefeng Wang · 2023 · Frontiers in Cell and Developmental Biology
93. Predicting which genes will respond to transcription factor perturbations
    Yiming Kang, Wooseok J. Jung, Michael R. Brent · 2022 · G3 Genes Genomes Genetics
94. At the Intersection of Epigenetics and Regeneration: An Analysis of the Experimental Outlook of Organoid Technology
    Nicolò Caporale, Giuseppe Testa · 2019 · Elsevier eBooks
95. Large scale control and programming of gene expression using CRISPR
    Matthew Deyell, Sandeep Ameta, Philippe Nghe · 2019 · Seminars in Cell and Developmental Biology
96. A statistical framework for predicting critical regions of p53-dependent enhancers
    Xiaohui Niu, Kaixuan Deng, Lifen Liu, Kun Yang, Xuehai Hu · 2020 · Briefings in Bioinformatics
97. Predicting the effect of CRISPR-Cas9-based epigenome editing
    Sanjit Singh Batra, Alan Cabrera, Jeffrey P. Spence, Jacob Goell, Selvalakshmi S Anand, Isaac B. Hilton, Yun S Song · 2023 · eLife
98. A systematic survey of distal element-gene regulatory interactions with Direct-Capture Targeted Perturb-seq
    Judhajeet Ray, Evelyn Jagoda, Maya U. Sheth, James Galante, Dulguun Amgalan, Eugenio Mattei, Andreas R. Gschwind, Chad J. Munger, Jacob Huang, Glen Munson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
99. dCas9-mediated dysregulation of gene expression in human induced pluripotent stem cells during primitive streak differentiation
    Viktor Haellman, Martin Pirkl, Arslan Akmammedov, Pratik Saxena, Niko Beerenwinkel, Renato Paro, Ana P. Teixeira, Martin Fussenegger · 2022 · Metabolic Engineering
100. Awakening the Genome: CRISPR Activation to Unravel the Origin and Vulnerabilities of Cancer
     John E. La Marca, Sarah T. Diepstraten, Gemma L. Kelly, Marco J. Herold · 2024 · Annual Review of Cancer Biology